Shareholder Information
Share management and Shareholder Meeting information
June 2025 Investor Presentation
June 2 2025 Download (2.27MB)Indivior Q1 2025 Financial Results
April 24 2025 Download (153KB)Annual Report and Accounts 2024
March 17 2025 Download (7.25MB)Indivior FY and Q4 2024 Financial Results
February 20 2025 Download (589KB)Indivior Announces Q3 2024 Financial Results
October 24 2024 Download (334KB)Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained
July 25 2025Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder
July 23 2025Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs
July 8 2025Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes
June 30 2025Indivior Appoints Tony Kingsley to the Board of Directors
June 24 2025